AltheaDx Adds Next-Gen Sequencing Services for Biomarker Discovery, Clinical Trial Testing

The firm plans to provide pharmaceutical and biotechnology customers with well-characterized predictive biomarker panels of genetic polymorphisms and gene expression patterns.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.